BluePath Capital Management’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.18M Buy
13,021
+1,269
+11% +$116K 0.65% 59
2026
Q1
$1.21M Buy
11,752
+2,260
+24% +$255K 0.83% 36
2025
Q4
$1.19M Buy
9,492
+1,709
+22% +$218K 0.8% 37
2025
Q3
$1.04M Buy
7,783
+1,213
+18% +$159K 0.76% 48
2025
Q2
$894K Buy
6,570
+251
+4% +$33.1K 0.79% 49
2025
Q1
$838K Sell
6,319
-2,960
-32% -$377K 0.87% 26
2024
Q4
$1.05M Buy
9,279
+1,800
+24% +$208K 0.56% 43
2024
Q3
$853K Buy
7,479
+1,520
+26% +$167K 0.53% 51
2024
Q2
$619K Buy
5,959
+2,044
+52% +$217K 0.43% 72
2024
Q1
$445K Buy
3,915
+602
+18% +$69K 0.34% 79
2023
Q4
$379K Sell
3,313
-192
-5% -$19.2K 0.32% 72
2023
Q3
$339K Buy
+3,505
New +$368K 0.31% 65

Other funds holding ABT

BluePath Capital Management's ABT Position: Q2 2026 in Review

BluePath Capital Management increased its Abbott (ABT) stake by 11% in Q2 2026, buying an estimated $116K and bringing the position to 13,021 shares worth $1.18M. The position accounts for 0.65% of the portfolio, ranked #59.

BluePath Capital Management first reported a position in ABT in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.21M in Q1 2026. 940 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • BluePath Capital Management held 13,021 shares of Abbott worth $1.18M as of Q2 2026.
  • BluePath Capital Management bought 1,269 Abbott shares in Q2 2026, an estimated $116K.
  • Abbott made up 0.65% of BluePath Capital Management's portfolio in Q2 2026, its #59 holding.
  • BluePath Capital Management first reported a position in Abbott in Q3 2023 and has held it in 12 quarters since.
  • BluePath Capital Management's Abbott position peaked at $1.21M in Q1 2026.
  • 940 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on BluePath Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.